NCT04716634 2025-03-25Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid TumorsBeiGenePhase 2 Completed84 enrolled 17 charts
NCT03251378 2024-09-25A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersHutchmedPhase 1 Completed129 enrolled 32 charts
NCT02196688 2020-06-16Study of Fruquintinib in Patients With Metastatic Colorectal CancerHutchmedPhase 2 Completed71 enrolled 13 charts